Home › Compare › SPKAR vs JNJ

SPKAR vs JNJ: Dividend Comparison 2026

SPKAR yields 133333.33% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPKAR wins by $8.549287649225948e+27M in total portfolio value
10 years
SPKAR
SPKAR
● Live price
133333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.549287649225948e+27M
Annual income
$8,536,692,923,921,903,000,000,000,000,000,000.00
Full SPKAR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SPKAR vs JNJ

📍 SPKAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPKARJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPKAR + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SPKAR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPKAR
Annual income on $10K today (after 15% tax)
$11,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$7,256,188,985,333,618,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SPKAR beats the other by $7,256,188,985,333,618,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPKAR + JNJ for your $10,000?

SPKAR: 50%JNJ: 50%
100% JNJ50/50100% SPKAR
Portfolio after 10yr
$4.274643824612974e+27M
Annual income
$4,268,346,461,960,951,400,000,000,000,000,000.00/yr
Blended yield
99.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPKAR
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPKAR buys
0
JNJ buys
0
No recent congressional trades found for SPKAR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPKARJNJ
Forward yield133333.33% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8.549287649225948e+27M$20.0K ✓
Annual income after 10y$8,536,692,923,921,903,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$8.548462633639563e+27M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPKAR vs JNJ ($10,000, DRIP)

YearSPKAR PortfolioSPKAR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,344,033$13,333,333.33$10,676$355.77+$13.33M → SPKAR
2$16,642,357,036$16,628,078,920.04$11,407$389.39+$16642.35M → SPKAR
3$19,399,246,208,345$19,381,438,886,316.95$12,198$426.53+$19399246.20M → SPKAR
4$21,134,841,850,983,004$21,114,084,657,540,070.00$13,056$467.62+$21134841850.97M → SPKAR
5$21,520,840,488,109,330,000$21,498,226,207,328,780,000.00$13,987$513.12+$21520840488109.32M → SPKAR
6$20,481,776,417,848,300,000,000$20,458,749,118,526,020,000,000.00$14,998$563.56+$20481776417848300.00M → SPKAR
7$18,219,078,762,075,947,000,000,000$18,197,163,261,308,848,000,000,000.00$16,098$619.52+$18219078762075947008.00M → SPKAR
8$15,147,396,542,885,863,000,000,000,000$15,127,902,128,610,440,000,000,000,000.00$17,295$681.69+$1.5147396542885863e+22M → SPKAR
9$11,770,771,312,189,630,000,000,000,000,000$11,754,563,597,888,743,000,000,000,000,000.00$18,599$750.82+$1.1770771312189631e+25M → SPKAR
10$8,549,287,649,225,948,000,000,000,000,000,000$8,536,692,923,921,903,000,000,000,000,000,000.00$20,022$827.78+$8.549287649225948e+27M → SPKAR

SPKAR vs JNJ: Complete Analysis 2026

SPKAR — Stock

SPKAR is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SPKAR shares.

Full SPKAR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SPKAR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPKAR vs SCHDSPKAR vs JEPISPKAR vs OSPKAR vs KOSPKAR vs MAINSPKAR vs ABBVSPKAR vs MRKSPKAR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.